Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing

Medical Mycology

Volumn 49, Issue 1, 2010, Pages 107-110

  Vijgen, Sara ^a   Nys, Sita ^a   Naesens, Reinout ^a   Magerman, Koen ^a   Boel, An ^b   Cartuyvels, Reinoud ^a  

^a JESSA HOSPITAL   (Belgium)

^b OLV HOSPITAL   (Belgium)

Author keywords

Candida; Identification; Sensititre YeastOne; Susceptibility testing; Vitek 2

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA GLABRATA; COLORIMETRY; DNA SEQUENCE; FUNGAL STRAIN; FUNGUS ISOLATION; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPHOTERICIN B; CANDIDA; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; PYRIMIDINES; TRIAZOLES;

CANDIDA; CANDIDA GLABRATA;

EID: 78650333092     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.494255     Document Type: Article

References (21)

1. Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 15: 1695-1703.
2. Lewis RE. Overview of the changing epidemiology of candidemia. Curr Med Res Opin 2009; 25: 1732-1740.
3. Clinical and Laboratory Standards Institute (CLSI). R eference method for broth dilution antifungal susceptibility testing of yeasts ; CLSI document M27-S3. Wayne, PA:CLSI , 2008.
4. Davey K, Szekeley A, Johnson E, Warnock D. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans . J Antimicrob Chemother 1998; 42: 439-444.
5. Espinel-Ingroff A, Pfaller M, Messer S, et al. Multicenter comparison of the Sensititre YeastOne Colorimetric Antifungal panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing of clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J Clin Microbiol 1999; 37: 591-595.
6. Pfaller M, Espinel-Ingroff A, Jones R. Clinical evaluation of the Sensititre YeastOne Colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles, voriconazole, posaconazole and ravuconazole. J Clin Microbiol 2004; 42: 4577-4580.
7. Espinel-Ingroff A, Pfaller M, Messer S, et al. Multicenter comparison of the Sensititre YeastOne Colorimetric Antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J Clin Microbiol 2004; 42: 718-721. (Pubitemid 38222652)
8. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts ; CLSI document M27-A3. Wayne, PA:CLSI, 2008.
9. De Baere T, Van Keerberghen A, Van Hauwe P, et al. An interlaboratory comparison of ITS2-PCR for the identifi cation of yeasts, using the ABI Prism 310 and CEQ8000 capillary electrophoresis systems. BMC Microbiol 2005; 18: 14.
10. Graf B, Adam T, Zill E, Göbel UB. Evaluation of the VITEK 2 system for rapid identifi cation of yeasts and yeast-like organisms. J Clin Microbiol 2000; 38: 1782-1785.
11. Loïez C, Wallet F, Sendid B, Courcol RJ. Evaluation of VITEK 2 colorimetric cards versus fl uorimetric cards for identifi cation of yeasts. Diagn Microbiol Infect Dis 2006; 56: 455-457.
12. Aubertine CL, Rivera M, Rohan SM, Larone DH. Comparative study of the new colorimetric VITEK 2 yeast identifi cation card versus the older fl uorometric card and of CHROMagar Candida as a source medium with the new card. J Clin Microbiol 2006; 44: 227-228.
13. Meurman O, Koskensalo A, Rantakokko-Jalava K. Evaluation of VITEK 2 for identifi cation of yeasts in the clinical laboratory. Clin Microbiol Infect 2006; 12: 591-593.
14. Valenza G, Strasen J, Schä fer F, et al. Evaluation of new colorimetric Vitek 2 yeast identifi cation card by use of different source media. J Clin Microbiol 2008; 46: 3784-3787.
15. Sanguinetti M, Porta R, Sali M, et al. Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identifi cation: experience at a large clinical microbiology laboratory. J Clin Microbiol 2007; 45: 1343-1346.
16. Massonet C, Van Eldere J, Vaneechoutte M, et al. Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identifi cation of yeast species. J Clin Microbiol 2004; 42: 2209-2211.
17. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the Vitek 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fl uconazole against Candida spp. J Clin Microbiol 2007; 45: 796-802.
18. Posteraro B, Martucci R, La Sorda M, et al. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fl uconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata . J Clin Microbiol 2009; 47: 1927-1930.
19. Bourgeois N, Dehandschoewercker L, Bertout S, et al. Antifungal susceptibility of 205 Candida spp. primarily isolated during invasive candidiasis. Comparison of the Vitek 2 system with CLSI microdilution and Etest methods. J Clin Microbiol 2010; 48:154-161.
20. Pfaller M A, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, fl ucytosine, and voriconazole against Candida spp. J Clin Microbiol 2007; 45: 3522-3528.
21. Cuenca-Estrella M, Gomez-Lopez A, Alastruey-Izquierdo A, et al. Comparison of the Vitek 2 antifungal susceptibility system with the CLSI and the EUCAST broth microdilution reference methods and with the Sensititre Yeast-One and the Etest techniques for the detection in vitro of antifungal resistance in yeasts. J Clin Microbiol 2010 Mar 10 [Epub ahead of print].